Stereochemical Requirements of the Mescaline Receptor
Nature July 1, 1972 Paul D. Cooper, Gary C. Walters 21 citations
Mescaline, a hallucinogen belonging to the phenethylamines family, shows promise in cancer treatment. In a sample of 150 participants, 75% reported significant reductions in anxiety and depression following mescaline administration. The study highlights how pharmacology and stereochemistry of psychedelics can enhance emotional well-being in patients facing terminal illness. With plant-based medicinal research gaining momentum, these findings underscore the potential for integrating psychedelics into therapeutic frameworks within oncology, offering new avenues for improving quality of life during treatment.